Fig. 6: Assessing the role of modules in ADs and functional analysis for each module.

A GSEA was performed on the ranked gene list for each AD. The top 10 gene sets (modules) with positive Normalized Enrichment Scores (NES) for each disease are shown, where the dot size represents the number of genes enriched per term. B Pathway enrichment analysis for each module was conducted using KEGG, Reactome, Wikipathways and GO biological process databases via g:profiler. The number of drugs in clinical trials (phases III and IV, ChEMBL) and their respective targets are listed for each module.